Genus (GNS)

Sector:

Pharma and Biotech

Index:

FTSE 250

2,256.00p
   
  • Change Today:
      2.00p
  • 52 Week High: 3,170.00
  • 52 Week Low: 1,966.00
  • Currency: UK Pounds
  • Shares Issued: 66.54m
  • Volume: 62,243
  • Market Cap: £1,501.16m
  • RiskGrade: 128
  • Beta: 0.01

Latest ShareCast News

Genus sees FY 'moderately ahead' of expectations, shares rise

By Frank Prenesti

Date: Tuesday 14 Jul 2026

(Sharecast News) - Animal genetics company Genus on Tuesday said it expected annual earnings to be moderately above expectations after a strong second half in Asia and Latin America that more than offset weaker conditions in North America, sending shares in the firm 5% higher.

Berenberg reiterates 'buy' rating on Genus

By Iain Gilbert

Date: Tuesday 14 Jul 2026

(Sharecast News) - Analysts at Berenberg maintained their 'buy' rating on Genus on Tuesday as it said the animal genetics firm's latest trading update showed strong momentum across the business, prompting another upgrade to full‑year guidance and extending what the broker described as a sustained run of improvements since early 2025.

Director dealings: Genus non-executive director snaps up 2,336 shares

By Iain Gilbert

Date: Monday 29 Jun 2026

(Sharecast News) - Genus revealed on Monday that non-executive director Celia Baxter had acquired 2,336 ordinary shares in the FTSE 250-listed biotech firm.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

Genus Market Data

Currency UK Pounds
Share Price 2,256.00p
Change Today 2.00p
% Change 0.09 %
52 Week High 3,170.00
52 Week Low 1,966.00
Volume 62,243
Shares Issued 66.54m
Market Cap £1,501.16m
Beta 0.01
RiskGrade 128

Genus Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
92.49% below the market average92.49% below the market average92.49% below the market average92.49% below the market average92.49% below the market average
100% below the sector average100% below the sector average100% below the sector average100% below the sector average100% below the sector average
Price Trend
78.22% above the market average78.22% above the market average78.22% above the market average78.22% above the market average78.22% above the market average
90.91% above the sector average90.91% above the sector average90.91% above the sector average90.91% above the sector average90.91% above the sector average
Income
98.6% below the market average98.6% below the market average98.6% below the market average98.6% below the market average98.6% below the market average
100% below the sector average100% below the sector average100% below the sector average100% below the sector average100% below the sector average
Growth
91.76% below the market average91.76% below the market average91.76% below the market average91.76% below the market average91.76% below the market average
100% below the sector average100% below the sector average100% below the sector average100% below the sector average100% below the sector average

Genus Dividends

  Latest Previous
  Interim Final
Ex-Div 05-Mar-26 06-Nov-25
Paid 27-Mar-26 05-Dec-25
Amount 11.20p 21.70p

Trades for 14-Aug-2026

Time Volume / Share Price
16:35 267 @ 2,256.00p
16:35 6 @ 2,256.00p
16:35 48,430 @ 2,256.00p
16:35 1 @ 2,256.00p
16:35 60 @ 2,256.00p

Genus Key Personnel

CEO Jorgen Kokke
CFO Andy Russell

Top of Page